Trevena Inc (OQ:TRVN)

Feb 13, 2020 07:00 am ET
Trevena Appoints Scott Applebaum as Chief Legal and Compliance Officer and SVP of Regulatory Affairs
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the appointment of Scott Applebaum as Chief...
Feb 10, 2020 07:01 am ET
Trevena Resubmits New Drug Application for Oliceridine
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it has resubmitted its New Drug Application...
Feb 05, 2020 07:00 am ET
Trevena to Present at the 2020 BIO CEO & Investor Conference
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President and Chief...
Dec 23, 2019 07:00 am ET
Trevena Announces Initiation of Proof-of-Concept Study for TRV734 for Potential Treatment of Opioid Use Disorder
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the initiation of a proof-of-concept study for...
Dec 12, 2019 07:00 am ET
Trevena Presents Phase 1 Data on TRV250 for Acute Migraine at American College of Neuropsychopharmacology 2019 Annual Meeting
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced a poster presentation at the 58th Annual Meeting...
Nov 20, 2019 07:00 am ET
Trevena Announces Publication of Results from Phase 3 “Real World” Safety Study for Oliceridine in The Journal of Pain Research
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced publication of results from the Phase 3...
Nov 20, 2019 07:00 am ET
Trevena Announces Publication of Results from Special Population Studies for Oliceridine
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced publication of results from two Phase 1...
Nov 18, 2019 05:05 pm ET
Trevena to Present at the Stifel 2019 Healthcare Conference
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Mark Demitrack, M.D., Senior Vice President...
Nov 04, 2019 07:00 am ET
Trevena Reports Third Quarter 2019 Results and Topline Data From Multi-Dose Healthy Volunteer QT Study
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced topline results from its multi-dose QT study for...
Oct 21, 2019 10:30 am ET
Trevena Announces Presentations at the American Society of Anesthesiologists 2019 Annual Meeting
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) conditions, today announced four presentations at ANESTHESIOLOGY® 2019, the...
Sep 27, 2019 07:00 am ET
Trevena to Present at the 2019 Cantor Global Healthcare Conference
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System (CNS) conditions, today announced that its management team will present at the...
Sep 20, 2019 08:46 am ET
Johnson Fistel, LLP Announces Investigations of Trevena, Inc. and IVERIC bio, Inc.; Long Term Investors Encouraged to Contact the Firm
SAN DIEGO, Sept. 20, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against the following companies: ...
Sep 03, 2019 07:00 am ET
Trevena to Participate in Upcoming Conferences in September 2019
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System (CNS) conditions, today announced that its management team will participate in...
Aug 30, 2019 10:50 pm ET
TREVENA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Trevena, Inc. - TRVN
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Trevena, Inc. (NasdaqGS: TRVN).
Aug 28, 2019 04:01 pm ET
Trevena Advances NDA Resubmission Activities for Oliceridine
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System (CNS) conditions, today provided an update on the activities to support...
Aug 07, 2019 07:00 am ET
Trevena Reports Second Quarter 2019 Results
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System (CNS) conditions, today reported its financial results for the second quarter...
Jul 31, 2019 07:00 am ET
Trevena to Report Second Quarter 2019 Results on August 7, 2019
Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System (CNS) conditions, today announced that it will release its financial results for...
Jul 19, 2019 10:50 pm ET
TREVENA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Trevena, Inc. - TRVN
NEW ORLEANS, July 19, 2019 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Trevena, Inc. (NasdaqGS: TRVN).  ...
Jun 27, 2019 07:00 am ET
Trevena Appoints Barry Shin as Chief Financial Officer
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System (CNS) conditions, today announced the appointment of Barry Shin as Chief...
Jun 24, 2019 07:00 am ET
Trevena Announces Publication of APOLLO-2 Results in Pain Practice
Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System (CNS) conditions, today announced publication of APOLLO-2 (pivotal Phase 3)...
Jun 20, 2019 07:00 am ET
Trevena Announces Initiation of Healthy Volunteer Study for Oliceridine
Trevena, Inc. (Nasdaq: TRVN) (“Trevena” or the “Company”), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System conditions, announced today that it has initiated...
May 31, 2019 10:50 pm ET
TREVENA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Trevena, Inc. - TRVN
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Trevena, Inc. (NasdaqGS: TRVN).
May 29, 2019 04:01 pm ET
Trevena to Participate in Upcoming Conferences in June 2019
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by Central Nervous System conditions, today announced that Carrie Bourdow, President and Chief...
May 10, 2019 07:00 am ET
Trevena Reports First Quarter 2019 Results
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by Central Nervous System (CNS) conditions, today announced receipt of comments from the U.S Food...
Apr 12, 2019 08:00 am ET
AMAG Pharmaceuticals Appoints New Members to Board of Directors
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the election of two new members to its Board of Directors—Anne Phillips, M.D., senior vice president, clinical development, medical and regulatory affairs for Novo Nordisk, Inc. and Kathrine...
Apr 05, 2019 02:00 am ET
Report: Developing Opportunities within 22nd Century Group, Darling Ingredients, Silvercorp Metals, Trevena, Star Bulk Carriers, and AngioDynamics — Future Expectations, Projections Moving into 2019
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of 22nd Century Group, Inc (NYSE:XXII), Darling Ingredients Inc. (NYSE:DAR),...
Mar 13, 2019 07:00 am ET
Trevena Reports Fourth Quarter and Full Year 2018 Results
Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS, today reported its financial...
Mar 11, 2019 07:00 am ET
Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain
Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS, today announced publication of...
Mar 04, 2019 07:00 am ET
Trevena to Report Fourth Quarter and Full Year 2018 Results on March 13, 2019
Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of new and innovative treatment options for patients in pain, today announced that it will release its financial results for the fourth...
Feb 06, 2019 08:31 am ET
Thinking about buying stock in Amyris Inc., Disney, Electronic Arts, Trevena Inc. or Take-Two Interactive?
NEW YORK, Feb. 6, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMRS, DIS, EA, TRVN, and TTWO....
Feb 05, 2019 06:58 pm ET
Trevena to Present at the 21st Annual BIO CEO & Investor Conference
Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of new and innovative treatment options for patients in pain, today announced it will be featured as a presenting company at the 21st Annual...
Feb 01, 2019 08:10 am ET
Market Trends Toward New Normal in CoreLogic, Nasdaq, Nevro, Blue Apron, Unisys, and Trevena — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of CoreLogic, Inc. (NYSE:CLGX), Nasdaq, Inc. (NASDAQ:NDAQ), Nevro Corp....
Jan 30, 2019 07:00 am ET
Trevena Announces $10 Million Registered Direct Offering of Common Stock
Trevena, Inc. (Nasdaq: TRVN) (the “Company”) today announced that it entered into securities purchase agreements with two healthcare-focused institutional investors, pursuant to which Trevena agreed to sell to the purchasers an aggregate of...
Jan 29, 2019 08:31 am ET
Thinking about buying stock in Avalon GloboCare Corp., MagneGas, Square Inc., Trevena Inc. or Verizon Communications?
NEW YORK, Jan. 29, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVCO, MNGA, SQ, TRVN, and VZ....
Jan 28, 2019 07:00 am ET
Trevena Announces Receipt of Type A Meeting Minutes and Provides Regulatory Update for Oliceridine
Trevena, Inc. (NASDAQ: TRVN) today announced the receipt of the official Type A meeting minutes from the U.S. Food and Drug Administration (FDA) regarding the Complete Response Letter (CRL) received for the oliceridine New Drug Application (NDA)....
Dec 13, 2018 04:01 pm ET
National Institute on Drug Abuse Presents Data on Trevena’s TRV734 at the 57th Annual Meeting of the American College of Neuropsychopharmacology
Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of new and innovative treatment options for patients in pain, today announced that TRV734 data were featured in a presentation at the 57th...
Dec 12, 2018 07:30 am ET
Report: Developing Opportunities within Exelixis, Cintas, BGC Partners, FirstEnergy, Hologic, and Trevena — Future Expectations, Projections Moving into 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Exelixis, Inc. (NASDAQ:EXEL), Cintas Corporation (NASDAQ:CTAS), BGC...
Dec 10, 2018 03:13 pm ET
SHAREHOLDER ALERT: TRVN GOOG GOOGL CWH HON FIT SYF RYAAY TSRO MGI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 10, 2018 11:30 am ET
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Trevena, Inc. (“Trevena” or “the Company”) (NASDAQ: TRVN) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
Dec 10, 2018 10:00 am ET
SHAREHOLDER ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Trevena, Inc. (TRVN) & Lead Plaintiff Deadline - December 10, 2018
Attorney Advertising--(PR Newswire)--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN) and certain of its officers, on behalf of shareholders...
Dec 10, 2018 07:00 am ET
Trevena Promotes Robert T. Yoder to Senior Vice President and Chief Business Officer
Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of new and innovative treatment options for patients in pain, today announced the promotion of Robert T. Yoder from Vice President Commercial...
Dec 09, 2018 11:00 am ET
CLASS ACTION UPDATE for TRVN, SFIX, GOOG and CWH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Dec 07, 2018 03:55 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Trevena, Inc. to Contact the Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ:TRVN) of the December 10, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Dec 07, 2018 02:17 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of APOG, TRVN, GOOG, NKTR and RYAAY
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 07, 2018 11:15 am ET
MONDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Trevena, Inc. (“Trevena” or “the Company”) (NASDAQ:
Dec 06, 2018 03:00 pm ET
SHAREHOLDER ALERT: JT TRVN HTHT OZK NKTR FIT GSKY ATUS PPDF MAR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 06, 2018 01:00 pm ET
MONDAY DEADLINE: The Schall Law Firm Announces it is Investigating Claims Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Trevena, Inc. (“Trevena” or “the Company”) (NASDAQ:
Dec 06, 2018 11:43 am ET
CLASS ACTION UPDATE for TRVN, HTHT and NKTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Dec 05, 2018 11:07 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TRVN, CWH, HON, OZK and ATUS
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 04, 2018 09:02 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch Fix, Trevena, and Funko and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Stitch Fix, Inc., Trevena, Inc., and Funko, Inc.  Stockholders have until the deadlines listed below to petition the court to...
Dec 04, 2018 05:19 pm ET
SHAREHOLDER ALERT: TRVN HTHT DY FIT RYAAY SONS BA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 04, 2018 04:33 pm ET
TRVN LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Trevena, Inc.; Important Dec. 10 Deadline - TRVN
NEW YORK, Dec. 4, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Trevena, Inc. (NASDAQ: TRVN) from May 2, 2016 through October 8, 2018, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Trevena investors under the federal securities laws. ...
Dec 04, 2018 02:09 pm ET
CLASS ACTION UPDATE for TRVN, SFIX and DY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Dec 04, 2018 10:00 am ET
SHAREHOLDER ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Trevena, Inc. (TRVN) & Lead Plaintiff Deadline - December 10, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN) and certain of its officers, on behalf of shareholders who purchased...
Dec 03, 2018 03:25 pm ET
SHAREHOLDER ALERT: JT TRVN GOOG CWH OZK NKTR SYF AQUA GSKY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 03, 2018 01:05 pm ET
UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Trevena, Inc. (“Trevena” or “the Company”) (NASDAQ: TRVN) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
Dec 02, 2018 12:00 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of JT, TRVN, HTHT, CWH and HON
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 30, 2018 05:17 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Trevena, Inc. of Class Action Lawsuit and Upcoming Deadline – TRVN
Pomerantz LLP announces that a class action lawsuit has been filed against Trevena Inc. (“Trevena or the “Company”) (NASDAQ:  TRVN) and certain of its officers.   The class action, filed in United States District Court, Eastern District of...
Nov 30, 2018 02:04 pm ET
CLASS ACTION UPDATE for TRVN, SFIX and CWH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Nov 29, 2018 12:09 pm ET
SHAREHOLDER ALERT: ADNT TRVN SFIX GOOG CWH OZK NKTR SYF GSKY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 28, 2018 03:41 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of APOG, TRVN, CWH, HON and DY
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 28, 2018 11:48 am ET
TREVENA INVESTOR NOTICE: Kaskela Law LLC Files Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Before Important Deadline – TRV
Kaskela Law LLC has filed a class action lawsuit against Trevena, Inc. (NASDAQ: TRVN) (“Trevena” or the “Company”) on behalf of purchasers of the Company’s securities between May 2, 2016 and October 8, 2018, inclusive (the “Class Period”)....
Nov 28, 2018 10:00 am ET
SHAREHOLDER ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Trevena, Inc. (TRVN) & Lead Plaintiff Deadline - December 10, 2018
Attorney Advertising  --  Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN) and certain of its officers, on behalf of shareholders who purchased...
Nov 27, 2018 08:31 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Trevena, Camping World, and Dycom and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Trevena, Inc., Camping World Holdings, Inc., and Dycom Industries, Inc.  Stockholders have until the deadlines listed below to...
Nov 27, 2018 07:41 pm ET
Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Trevena, Inc.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the December 10, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ:...
Nov 26, 2018 04:23 pm ET
CLASS ACTION UPDATE for TGTX, TRVN and DY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Nov 26, 2018 10:47 am ET
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Trevena, Inc. (“Trevena” or “the Company”) (NASDAQ: TRVN) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
Nov 25, 2018 10:00 am ET
SHAREHOLDER ALERT: MGTI TRVN HTHT IGCC FIT SYF TSRO EIX MDR ATUS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 23, 2018 06:07 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Trevena, Inc. of Class Action Lawsuit and Upcoming Deadline – TRVN
Pomerantz LLP announces that a class action lawsuit has been filed against Trevena Inc. (“Trevena or the “Company”) (NASDAQ:  TRVN) and certain of its officers.   The class action, filed in United States District Court, Eastern District of...
Nov 23, 2018 10:30 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HAS, CPB, ADNT, TRVN and GOOG
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 23, 2018 08:35 am ET
Investor Expectations to Drive Momentum within Capital One Financial, Trevena, CVD Equipment, Alpha Pro Tech, Horace Mann Educators, and Rubicon Technology — Discovering Underlying Factors of Influenc
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Capital One Financial Corporation (NYSE:COF), Trevena, Inc....
Nov 21, 2018 01:36 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Trevena, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ:TRVN) of the December 10, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Nov 21, 2018 10:15 am ET
CLASS ACTION UPDATE for TGTX, ALNY and TRVN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Nov 20, 2018 04:59 pm ET
SHAREHOLDER ALERT: MGTI TRVN HTHT IGCC FIT SYF EIX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 19, 2018 04:28 pm ET
SHAREHOLDER ALERT: APOG ALNY ACHC COST TRVN SFIX ALGN AQUA TSRO MGI MDR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 19, 2018 01:54 pm ET
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Trevena, Inc. (“Trevena” or “the Company”) (NASDAQ: TRVN) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
Nov 18, 2018 10:05 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ALNY, ACHC, TRVN, HTHT and SFIX
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 16, 2018 07:00 pm ET
Johnson Fistel Files Class Action Suit Against Trevena, Inc.
SAN DIEGO, Nov. 16, 2018 /PRNewswire/ -- Johnson Fistel, LLP announced that a class action has been commenced on behalf of purchasers of Trevena, Inc. (NASDAQ:TRVN) common stock during the period between May 2, 2016 and October 9, 2018 (the "Class Period")....
Nov 16, 2018 04:44 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Trevena, Inc. of Class Action Lawsuit and Upcoming Deadline – TRVN
Pomerantz LLP announces that a class action lawsuit has been filed against Trevena Inc. (“Trevena or the “Company”) (NASDAQ:  TRVN) and certain of its officers.  The class action, filed in United States District Court, Eastern District of...
Nov 16, 2018 02:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Trevena, Inc.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the December 10, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ:
Nov 16, 2018 10:54 am ET
CLASS ACTION UPDATE for TRVN, NKTR and SYF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Nov 14, 2018 04:04 pm ET
SHAREHOLDER ALERT: APOG COCP COST TRVN HON DY ALGN AQUA SONS TSRO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 13, 2018 04:10 pm ET
Robbins Arroyo LLP Reminds Investors of December 10, 2018 Lead Plaintiff Deadline in Class Action Against Trevena, Inc. (TRVN)
Shareholder rights law firm Robbins Arroyo LLP reminds investors that purchasers of Trevena, Inc. (NasdaqGS: TRVN) have filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between May 2, 2016 and October 9, 2018.
Nov 13, 2018 10:51 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of USAT, COCP, TRVN, HTHT and SFIX
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 12, 2018 08:10 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch Fix, Trevena, and Funko and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Stitch Fix, Inc., Trevena, Inc., and Funko, Inc.  Stockholders have until the deadlines listed below to petition the court to...
Nov 12, 2018 10:31 am ET
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Trevena, Inc. (“Trevena” or “the Company”) (NASDAQ: TRVN) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
Nov 11, 2018 12:00 am ET
SHAREHOLDER ALERT: ALNY ACHC JT TRVN HON DY AQUA SONS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 09, 2018 07:39 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Trevena, Inc. of Class Action Lawsuit and Upcoming Deadline – TRVN
Pomerantz LLP announces that a class action lawsuit has been filed against Trevena Inc. (“Trevena or the “Company”) (NASDAQ:  TRVN) and certain of its officers.  The class action, filed in United States District Court, Eastern District of...
Nov 09, 2018 01:12 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of APOG, JT, TRVN, HTHT and OZK
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 08, 2018 06:01 pm ET
CLASS ACTION UPDATE for CPB, JT and TRVN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Nov 08, 2018 12:11 pm ET
SHAREHOLDER ALERT: MCHP COCP ABBV JT TRVN SFIX CWH HON ALGN NKTR SYF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 08, 2018 07:00 am ET
Trevena Reports Third Quarter 2018 Financial Results and Announces Workforce Restructuring
Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of new and innovative treatment options for patients in pain, today reported third quarter 2018 financial results and announced a workforce...
Nov 07, 2018 05:23 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Trevena, Inc. of Class Action Lawsuit and Upcoming Deadline - TRVN
NEW YORK, Nov. 7, 2018 /CNW/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Trevena Inc. ("Trevena or the "Company") (NASDAQ:  TRVN) and certain of its officers.   The class action, filed in United States District Court, Eastern District of Pennsylvania, and indexed under 18-cv-04426, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise acquired Trevena securities between May 2, 2016 through October 9, 2018, both dates inclusive (the "Class Period"), seeking to recover damages cau...
Nov 07, 2018 05:23 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Trevena, Inc. of Class Action Lawsuit and Upcoming Deadline - TRVN
NEW YORK, Nov. 7, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Trevena Inc. ("Trevena or the "Company") (NASDAQ:  TRVN) and certain of its officers.   The class action, filed in United States District Court, Eastern District of Pennsylvania, and indexed under 18-cv-04426, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise acquired Trevena securities between May 2, 2016 through October 9, 2018, both dates inclusive (the "Class Period"), seeking to recover dama...
Nov 07, 2018 05:06 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Trevena, Inc. To Contact The Firm
NEW YORK, Nov. 7, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Trevena, Inc. ("Trevena" or the "Company") (NASDAQ:TRVN) of the December 10, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. ...
Nov 06, 2018 04:45 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TRVN, HON, OZK and NKTR
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 06, 2018 10:15 am ET
UPDATE: Kaskela Law LLC Files Shareholder Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Before Important Deadline – TRVN
Kaskela Law LLC has filed an investor class action lawsuit against Trevena, Inc. (NASDAQ: TRVN) (“Trevena” or the “Company”) on behalf of purchasers of the Company’s securities between May 2, 2016 and October 8, 2018, inclusive (the “Class...
Nov 06, 2018 09:00 am ET
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Trevena, Inc.
Robbins Geller Rudman & Dowd LLP (http://www.rgrdlaw.c
Nov 05, 2018 05:05 pm ET
SHAREHOLDER ALERT: TRCO MCHP TGTX HAS ADNT TRVN HTHT SFIX HON: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 05, 2018 03:27 pm ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Trevena, Inc. (“Trevena” or “the Company”) (NASDAQ: TRVN) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
Nov 04, 2018 12:05 pm ET
CLASS ACTION UPDATE for JT, TRVN and OZK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Nov 02, 2018 08:26 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Trevena, Inc. of Class Action Lawsuit and Upcoming Deadline – TRVN
Pomerantz LLP announces that a class action lawsuit has been filed against Trevena Inc. (“Trevena or the “Company”) (NASDAQ:  TRVN) and certain of its officers.   The class action, filed in United States District Court, Eastern District of...
Nov 02, 2018 07:58 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Trevena, Jianpu, and Bank OZK and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Trevena, Inc., Jianpu Technology Inc., and Bank OZK.  Stockholders have until the deadlines listed below to petition the court...
Nov 02, 2018 05:57 pm ET
Investor Alert: Kaplan Fox Announces Investigation Of Trevena Inc.
NEW YORK, Nov. 2, 2018 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Trevena Inc. ("Trevena" or the "Company") (NASDAQ: TRVN).  Investors who purchased Trevena securities between May 2, 2016 and October 9, 2018 (the "Class Period") may be affected.  A complaint has been filed in the United States District Court for the Eastern District of Pennsylvania against Trevena and certain executives on behalf of investors that purchased or otherwise acquired Trevena securities during the Class Period. ...
Nov 02, 2018 02:58 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TRVN, GOOG, HON and NKTR
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 02, 2018 01:42 pm ET
Trevena Receives Complete Response Letter for Oliceridine from FDA
Trevena, Inc. (NASDAQ: TRVN) today announced the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for oliceridine. “While we are disappointed with FDA’s...
Nov 02, 2018 10:00 am ET
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Trevena, Inc. (TRVN) & Lead Plaintiff Deadline: December 10, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN) and certain of its officers, on behalf of shareholders who purchased...
Nov 01, 2018 12:25 pm ET
SHAREHOLDER ALERT: SKX QRTEA MCHP TGTX ALNY HAS CPB TRVN HTHT NKTR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Oct 30, 2018 05:20 pm ET
CLASS ACTION UPDATE for CHGG, ADNT, TRVN and CWH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Oct 30, 2018 02:09 pm ET
SHAREHOLDER ALERT: Spector, Roseman & Kodroff, P.C. Announces Class Action Lawsuit Filed Against Trevena, Inc.
The law firm of Spector, Roseman & Kodroff, P.C. announces that a securities class action lawsuit has been filed on behalf of investors who purchased Trevena, Inc. (“Trevena”) (Nasdaq: TRVN) securities on the open market between May 2, 2016 and October 8, 2018 (the “Class Period”).
Oct 30, 2018 01:46 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADNT, TRVN, CWH and OZK
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Oct 29, 2018 05:33 pm ET
SHAREHOLDER ALERT: QRTEA TRCO USAT MCHP CHGG JT ADNT TRVN CWH DY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Oct 29, 2018 04:15 pm ET
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Trevena, Inc. (“Trevena” or “the Company”) (NASDAQ: TRVN) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
Oct 29, 2018 03:46 pm ET
CLASS ACTION UPDATE for TRVN, GOOG and DY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Oct 29, 2018 12:28 pm ET
Robbins Arroyo LLP: Trevena, Inc. (TRVN) Misled Shareholders According to Another Class Action
Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Trevena, Inc. (NasdaqGS: TRVN) have filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between May 2, 2016 and October 9, 2018. Trevena, a
Oct 28, 2018 11:05 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MGTI, HAS, TRVN, GOOG and DY
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Oct 26, 2018 06:57 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Trevena, Inc. of Class Action Lawsuit and Upcoming Deadline – TRVN
Pomerantz LLP announces that a class action lawsuit has been filed against Trevena Inc. (“Trevena or the “Company”) (NASDAQ:  TRVN) and certain of its officers.   The class action, filed in United States District Court, Eastern District of...
Oct 25, 2018 04:18 pm ET
SHAREHOLDER ALERT: MCHP ABBV MGTI HAS ACHC ADNT TRVN HTHT GOOG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Oct 24, 2018 03:58 pm ET
CLASS ACTION UPDATE for TRVN, HTHT and GOOG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Oct 23, 2018 10:49 am ET
SHAREHOLDER ALERT: CBS TRCO ALNY MGTI HAS CHGG ADNT TRVN HTHT GOOG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Oct 22, 2018 02:19 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CBS, COCP, TGTX and TRVN
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Oct 22, 2018 11:59 am ET
CLASS ACTION UPDATE for LCI, TRVN and GOOG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Oct 22, 2018 10:00 am ET
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Trevena, Inc. (TRVN) & Lead Plaintiff Deadline: December 10, 2018
Attorney Advertising -- Bronstein, Gewirtz Grossman, LLC notifies investors that a class action lawsuit has been filed Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN) and certain of its officers, on behalf of shareholders who purchased...
Oct 21, 2018 11:00 am ET
SHAREHOLDER ALERT: AMPE NVRO PZZA OPK QRTEA MCHP COCP TGTX CPB TRVN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Oct 19, 2018 07:58 pm ET
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Trevena, Inc. Investors (TRVN)
Glancy Prongay & Murray LLP (“GPM”) announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: 
Oct 18, 2018 02:49 pm ET
CLASS ACTION UPDATE for QRTEA, PVG, ADNT and TRVN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Oct 18, 2018 11:54 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TRCO, MCHP, CPB and TRVN
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Oct 17, 2018 05:48 pm ET
SHAREHOLDER ALERT: TRCO MCHP ALNY MGTI CPB CHGG ADNT TRVN SFIX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Oct 17, 2018 09:31 am ET
Thinking about buying stock in Blink Charging, Cronos Group, Helios and Matheson Analytics Inc, Sears Holdings or Trevena Inc.?
NEW YORK, Oct. 17, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BLNK, CRON, HMNY, SHLD, and TRVN....
Oct 16, 2018 08:00 pm ET
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Trevena, Inc. (TRVN)
Gainey McKenna Egleston announces that a class action lawsuit has been filed against Trevena, Inc. (“Trevena” or the “Company”) (Nasdaq: TRVN) in the United States District Court for the Eastern District of Pennsylvania on behalf of a class...
Oct 16, 2018 04:41 pm ET
TREVENA, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of
Wolf Haldenstein Adler Freeman Herz LLP  announces that  a federal class action lawsuit  has been  filed against  Trevena, Inc.  (“Trevena or  the “Company”) (NASDAQ: TRVN)   in the United States District  Court for the Eastern District of...
Oct 16, 2018 03:15 pm ET
Kaskela Law LLC Files Shareholder Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Before Important Deadline – TRVN
Kaskela Law LLC announces that it has filed a shareholder class action lawsuit against Trevena, Inc. (NASDAQ: TRVN) (“Trevena” or the “Company”) on behalf of purchasers of the Company’s securities between May 2, 2016 and October 8, 2018, inclusive...
Oct 16, 2018 11:43 am ET
CLASS ACTION UPDATE for TRVN and GOOG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Oct 16, 2018 09:42 am ET
Pomerantz Law Firm Announces the Filing of a Class Action against Trevena, Inc. and Certain Officers – TRVN
Pomerantz LLP announces that a class action lawsuit has been filed against Trevena Inc. (“Trevena or the “Company”) (NASDAQ: TRVN) and certain of its officers.   The class action, filed in United States District Court, Eastern District of...
Oct 15, 2018 03:34 pm ET
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Trevena, Inc. (“Trevena” or “the Company”) (NASDAQ:
Oct 15, 2018 03:01 pm ET
CLASS ACTION UPDATE for TRVN and SFIX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Oct 15, 2018 01:22 pm ET
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Trevena, Inc. Investors (TRVN)
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN) securities between May 2, 2018 and October 8, 2018, inclusive (the “Class Period”). Trevena investors have until December 10, 20
Oct 15, 2018 10:00 am ET
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Trevena, Inc. (TRVN) & Lead Plaintiff Deadline: December 10, 2018
Attorney Advertising -- Bronstein, Gewirtz Grossman, LLC notifies investors that a class action lawsuit has been filed Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN) and certain of its officers, on behalf of shareholders who purchased...
Oct 14, 2018 10:00 am ET
SHAREHOLDER ALERT: PDD AMPE MCHP MGTI HAS ADNT TRVN HTHT SFIX GOOG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Oct 12, 2018 06:03 pm ET
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Trevena, Inc. (“Trevena” or “the Company”) (NASDAQ:
Oct 12, 2018 04:46 pm ET
Robbins Arroyo LLP: Trevena, Inc. (TRVN) Misled Shareholders According to a Class Action
Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Trevena, Inc. (NasdaqGS: TRVN) have filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between May 2, 2016 and October 8, 2018. Trevena, a biophar
Oct 12, 2018 04:01 pm ET
Trevena to Present Phase 3, Open-Label Safety Study of Oliceridine at the American Society of Anesthesiologists Annual Meeting
Trevena, Inc. (NASDAQ: TRVN) today announced a poster presentation at ANESTHESIOLOGY® 2018, the national conference for the American Society of Anesthesiologists (ASA), taking place in San Francisco, CA, from October 13 – 17, 2018. The poster...
Oct 12, 2018 03:04 pm ET
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Trevena, Inc. (TRVN) & Lead Plaintiff Deadline: December 10, 2018
NEW YORK, Oct. 12, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed Trevena, Inc. ("Trevena" or the "Company") (NASDAQ: TRVN) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Trevena securities between May 2, 2016 and October 8, 2018, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/trvn. ...
Oct 12, 2018 01:06 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TRVN and SFIX
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Oct 12, 2018 10:05 am ET
Trevena Losses Alert: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Trevena, Inc. – TRVN
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Trevena, Inc. (“Trevena” or the “Company”)...
Oct 11, 2018 06:22 pm ET
Trevena Class Action Lawsuit: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Trevena, Inc. - TRVN
NEW YORK, Oct. 11, 2018 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Trevena, Inc. ("Trevena" or the "Company") (NASDAQ: TRVN) between May 2, 2016 and October 8, 2018, both dates inclusive (the "Class Period"). The lawsuit seeks to recover Trevena shareholders' investment losses....
Oct 11, 2018 06:12 pm ET
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Trevena, Inc. (TRVN) and Encourages TRVN Investors to Contact the Firm
Bragar Eagel Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of all persons or entities who purchased or otherwise acquired Trevena, Inc. (NASDAQ:...
Oct 11, 2018 06:05 pm ET
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Trevena, Inc. Investors (TRVN)
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ:
Oct 11, 2018 05:45 pm ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Trevena, Inc. – TRVN
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Trevena, Inc. (NASDAQ: TRVN) from May 2, 2016 through October 8, 2018, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Trevena investors under the federal securities laws.
Oct 11, 2018 05:45 pm ET
TREVENA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Trevena, Inc. To Contact The Firm
NEW YORK, Oct. 11, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Trevena, Inc. ("Trevena" or the "Company") (NASDAQ:TRVN)....
Oct 11, 2018 05:04 pm ET
Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
Trevena, Inc. (NASDAQ: TRVN), today announced the outcome of the meeting of the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) to review and discuss oliceridine. At the meeting, the...
Oct 11, 2018 04:31 pm ET
Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Trevena, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm – TRVN
Kaskela Law LLC announces that a class action lawsuit has been filed against Trevena, Inc. (NASDAQ: TRVN) (“Trevena” or the “Company”) on behalf of purchasers of the Company’s common stock between May 2, 2016 and October 8, 2018, inclusive (the...
Oct 11, 2018 03:48 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Trevena, Inc. Investors (TRVN)
Law Offices of Howard G. Smith announces an investigation on behalf of Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN) investors concerning the Company and its officers’ possible violations of federal securities laws.
Oct 11, 2018 02:44 pm ET
Block & Leviton Files Securities Class Action Against Trevena, Inc. (TRVN); Investors Are Encouraged to Contact The Firm
BOSTON, Oct. 11, 2018 /PRNewswire/ -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, announces that it has filed a securities fraud class action against Trevena, Inc. ("Trevena" or the "Company") (NASDAQ: TRVN) and certain of its officers alleging violations of the federal securities laws and encourages shareholders to contact Block & Leviton ahead of the December 10, 2018 lead plaintiff deadline. ...
Oct 11, 2018 01:42 pm ET
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Trevena, Inc.
Levi Korsinsky announces it has commenced an investigation of Trevena, Inc. (“Trevena” or “the Company”) (NASDAQGS: TRVN) concerning possible violations of federal securities laws. On May 2, 2016, Trevena announced it had “reached general...
Oct 11, 2018 12:42 pm ET
Bragar Eagel & Squire, P.C. is Investigating Trevena, Inc. (TRVN) on Behalf of Stockholders and Encourages TRVN Investors to Contact the Firm
Bragar Eagel Squire, P.C. is investigating potential claims against Trevena, Inc. (NASDAQ: TRVN).  Our investigation concerns whether Trevena has violated the federal securities laws and/or engaged in other unlawful business practices. On May 2,...
Oct 11, 2018 12:16 pm ET
INVESTOR ALERT: Investigation of Trevena Announced by Holzer & Holzer, LLC
Holzer & Holzer, LLC is investigating whether certain statements issued by Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN) complied with federal securities laws. On October 9, 2018, the minutes from Trevena’s April 28, 2016 meeting with the Food and Drug Administration (“FDA”) were released, which disclosed that the FDA “did not agree” with several aspects of Trevena’s Phase 3 study for Oliceridine. The price of Trevena’s stock declined following the report.
Oct 11, 2018 07:00 am ET
Trevena Stock Trading Halted; FDA Advisory Committee to Review Oliceridine for the Treatment of Moderate to Severe Acute Pain
Trevena, Inc. (NASDAQ: TRVN) today announced that NASDAQ has halted trading of the Company’s common stock. The U.S. Food and Drug Administration’s (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) is meeting today to review...
Oct 10, 2018 08:22 pm ET
INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Trevena Inc.
The law firm of Kirby McInerney LLP is investigating potential claims against Trevena Inc. (“Trevena” or the “Company”) (NASDAQ:TRVN). This investigation concerns whether Trevena has violated federal securities laws and/or engaged in other unlawful business practices.
Oct 10, 2018 03:05 pm ET
Trevena Losses Alert: Bernstein Liebhard LLP Announces Investigation of Trevena, Inc. - TRVN
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN) resulting from allegations that...
Oct 10, 2018 01:47 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Trevena, Inc.
Levi Korsinsky announces it has commenced an investigation of Trevena, Inc. (“Trevena” or “the Company”) (NASDAQGS: TRVN) concerning possible violations of federal securities laws. On May 2, 2016, Trevena announced it had “reached general...
Oct 10, 2018 11:02 am ET
Trevena Losses Alert: Bernstein Liebhard LLP Announces Investigation Of Trevena, Inc. - TRVN
NEW YORK, Oct. 10, 2018 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Trevena, Inc. ("Trevena" or the "Company") (NASDAQ: TRVN) resulting from allegations that Trevena and/or its executives may have issued materially misleading business information to the investing public. ...
Oct 09, 2018 02:29 pm ET
Trevena (TRVN) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws
BOSTON, Oct. 9, 2018 /PRNewswire/ -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Trevena, Inc. ("Trevena" or the "Company") (NASDAQ: TRVN) and certain of its officers and directors violated federal securities laws....
Oct 01, 2018 07:00 am ET
Trevena announces completion of leadership transition and appointment of new director
Trevena, Inc. (NASDAQ: TRVN), today announced the completion of its previously announced leadership transition with Carrie L. Bourdow, formerly the Company’s Executive Vice President and Chief Operating Officer, assuming the role of President and...
Sep 10, 2018 04:01 pm ET
Trevena to Present Oliceridine, a Next Generation IV Opioid for the Management of Moderate to Severe Acute Pain, at FDA Advisory Committee Meeting on October 11, 2018
Trevena, Inc. (NASDAQ: TRVN), today announced that the U.S. Food and Drug Administration (FDA) has scheduled a meeting of the Anesthetic and Analgesic Drug Products Advisory Committee on October 11, 2018 in Silver Spring, MD, to discuss the safety...
Aug 30, 2018 04:30 pm ET
Trevena to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
Trevena, Inc. (NASDAQ:TRVN) today, announced it will be featured as a presenting company at the 20th Annual Rodman Renshaw Global Investment Conference, sponsored by H.C. Wainwright Co., LLC. on Wednesday, September 5, 2018 in New York, NY....
Aug 02, 2018 07:00 am ET
Trevena Reports Second Quarter 2018 Financial Results
Trevena, Inc. (NASDAQ: TRVN) today announced financial results for the quarter ended June 30, 2018 and provided an update on its pipeline of differentiated new chemical entities, including its lead asset, oliceridine, currently under review by the...
Jun 28, 2018 04:01 pm ET
Trevena announces successful completion of Phase 1 study of TRV250 for acute migraine
Trevena, Inc. (NASDAQ:TRVN) announced today the successful completion of its first-time-in-human Phase 1 study of TRV250, a biased delta receptor agonist that the Company is developing for the treatment of acute migraine.  Preclinical data...
Jun 11, 2018 04:01 pm ET
Trevena Expands Commercial and Medical Affairs Leadership Teams with Key Hires
Trevena, Inc. (NASDAQ:TRVN) announced today the recent additions of three key members to its leadership team. The Company has appointed Linda Wase, M.D. as Vice President of Medical Affairs, Michael Catalano as Vice President of Marketing, and Bob...
May 30, 2018 04:01 pm ET
Trevena to Present at the Jefferies Global Healthcare Conference
Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the Jefferies Global Healthcare Conference on Wednesday, June 6th, 2018, at 3:30 p.m. EDT in New York, NY. To join a live audio webcast of the presentation, please visit the...
May 22, 2018 07:00 am ET
Trevena announces presentations at the American Society of Colon and Rectal Surgeons 2018 Annual Scientific Meeting
Trevena, Inc. (NASDAQ:TRVN) today announced two presentations at the American Society of Colon and Rectal Surgeons 2018 Annual Scientific Meeting, held in Nashville, Tennessee, May 19-23. The first poster highlighted efficacy, safety and...
May 21, 2018 05:13 pm ET
Trevena Appoints Mark A. Demitrack, M.D., as Chief Medical Officer
Trevena, Inc. (NASDAQ:TRVN) today announced the appointment of Mark Demitrack, M.D., as Senior Vice President and Chief Medical Officer.  Dr. Demitrack brings over 20 years of industry experience at large and small biopharmaceutical companies where...
May 08, 2018 04:01 pm ET
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company approved, effective as of May 2, 2018, the grant of inducement stock options to purchase 27,000 shares of the Company's...
May 03, 2018 07:00 am ET
Trevena Reports First Quarter 2018 Financial Results
Trevena, Inc. (NASDAQ:TRVN) today announced financial results for the quarter ended March 31, 2018 and provided an update on its pipeline of differentiated new chemical entities, including its lead asset, oliceridine, currently under review by the...
May 02, 2018 04:01 pm ET
Trevena to Present at the Deutsche Bank 43rd Annual Healthcare Conference
Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the Deutsche Bank 43rd Annual Healthcare Conference on Tuesday, May 8th, 2018, at 3:30 p.m. EDT in Boston, MA. To join a live audio webcast of the presentation, please...
May 01, 2018 04:01 pm ET
Trevena Inc. and Jiangsu Nhwa Pharmaceutical Co. Ltd Announce License Agreement for Oliceridine in China
– Nhwa granted a license to develop, manufacture, and commercialize oliceridine in China –
Apr 27, 2018 08:00 am ET
Trevena and Pharmbio Korea Announce License and Commercialization Agreement for Oliceridine in South Korea
– Pharmbio Korea granted a license to develop, manufacture, and commercialize oliceridine in South Korea –
Apr 26, 2018 04:01 pm ET
Trevena to Report First Quarter 2018 Financial Results on May 3, 2018
CHESTERBROOK, Pa., April 26, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will host a conference call and webcast on Thursday, May 3, 2018 at 8:00 am EDT to review financial results for the quarter...
Apr 26, 2018 08:20 am ET
New Research: Key Drivers of Growth for OFG, Oshkosh, Vishay Precision Group, Endocyte, BioCryst Pharmaceuticals, and Trevena — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of OFG Bancorp (NYSE:OFG), Oshkosh Corporation (NYSE:OSK),...
Apr 05, 2018 04:05 pm ET
Trevena Announces Retirement of Maxine Gowen, Ph.D., Effective October 1, and Planned Promotion of Carrie L. Bourdow to President and Chief Executive Officer
CHESTERBROOK, Pa., April 05, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that President and Chief Executive Officer Maxine Gowen, Ph.D., will retire on October 1, 2018.  The Board of Directors has selected Carrie L. Bourdow, who...
Mar 20, 2018 04:01 pm ET
Trevena to Present at the Needham & Company 17th Annual Healthcare Conference
CHESTERBROOK, Pa., March 20, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the Needham & Company 17th Annual Healthcare Conference on Tuesday, March 27, 2018, at 2:30 p.m. EDT in New...
Mar 14, 2018 04:01 pm ET
Trevena to Present at the Oppenheimer & Company 28th Annual Healthcare Conference
CHESTERBROOK, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the Oppenheimer & Company 28th Annual Healthcare Conference on Wednesday, March 21, 2018, at 2:45 p.m. EDT in New...
Mar 07, 2018 04:01 pm ET
Trevena to Present at the Cowen and Company 38th Annual Healthcare Conference
CHESTERBROOK, Pa., March 07, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the Cowen and Company 38th Annual Healthcare Conference on Wednesday, March 14, 2018, at 8:40 a.m. ET in Boston,...
Mar 07, 2018 07:00 am ET
Trevena Reports Full Year 2017 Earnings
– OLINVO™ (oliceridine) Injection New Drug Application submitted and accepted for review by FDA, with PDUFA date of November 2, 2018 –
Mar 02, 2018 04:01 pm ET
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHESTERBROOK, Pa., March 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company approved, effective as of February 19, 2018, the grant of inducement stock...
Feb 28, 2018 07:00 am ET
Trevena to Host Conference Call on March 7th to Discuss Full Year 2017 Financial Results
CHESTERBROOK, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will host a conference call on Wednesday, March 7, 2018 at 8:00 am EST to review financial results as of and for the...
Feb 15, 2018 07:40 am ET
New Research Coverage Highlights Trevena, Five Prime Therapeutics, Endocyte, FireEye, CSRA, and Orchid Island Capital — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Feb. 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Trevena, Inc. (NASDAQ:TRVN), Five Prime Therapeutics,...
Feb 02, 2018 07:00 am ET
Trevena Promotes Carrie Bourdow to Executive Vice President and Chief Operating Officer
CHESTERBROOK, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced the promotion of Carrie L. Bourdow from Senior Vice President and Chief Commercial Officer to Executive Vice President and Chief Operating Officer, effective immediately.  Ms....
Jan 02, 2018 04:01 pm ET
Trevena Announces FDA Acceptance for Review of New Drug Application for OLINVO™ (oliceridine) Injection
CHESTERBROOK, Pa., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for OLINVO™ (oliceridine) Injection.  The Company expects that the PDUFA...
Nov 30, 2017 08:30 am ET
Analysis: Positioning to Benefit within FireEye, CSRA, Concho Resources, Trevena, Five Prime Therapeutics, and Endocyte — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of FireEye, Inc. (NASDAQ:FEYE), CSRA Inc....
Nov 07, 2017 07:00 am ET
Trevena Reports Third Quarter 2017 Financial Results and Announces New Positive Clinical Trial Data
– New ATHENA data show OLINVO effectiveness with promising safety/tolerability in key target procedures –
Nov 02, 2017 07:00 am ET
Trevena Announces Submission of New Drug Application to U.S. FDA for OLINVO™ (oliceridine injection)
– Filing supported by positive Phase 3 APOLLO and ATHENA studies –
Nov 01, 2017 07:00 am ET
Trevena to Report Third Quarter 2017 Financial Results on November 7, 2017
CHESTERBROOK, Pa., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will host a conference call and webcast on Tuesday, November 7, 2017 at 8:00 am EST to review financial results for the quarter...
Oct 25, 2017 04:01 pm ET
Trevena Announces Publication and Presentations of OLINVO™ (oliceridine injection) Clinical Data
– American Society of Anesthesiologists Annual Meeting presentations highlight OLINVO data from positive Phase 3 trials –...
Sep 07, 2017 04:01 pm ET
Trevena Announces Presentations during PAINWeek® 2017
– Hospital charge database study shows high prevalence of opioid-related adverse events in key surgical specialties despite use of multimodal analgesia –...
Aug 31, 2017 04:01 pm ET
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHESTERBROOK, Pa., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company approved, effective as of August 28, 2017, the grant of inducement stock options to purchase 13,500 shares of the Company’s common stock to Michele Hummel, a new employee. These awards were granted pursuant to the Trevena, Inc. Inducement Plan as an inducement material to the new employees entering into employment with the Company, in accordance with NASDAQ Listing Rule 5635(c)(4). ...
Aug 14, 2017 04:01 pm ET
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHESTERBROOK, Pa., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company approved, effective as of July 31, August 7, and August 10, 2017, the grant of inducement stock options to purchase an aggregate of 87,000 shares of the Company’s common stock to four new employees. These awards were granted pursuant to the Trevena, Inc. Inducement Plan as an inducement material to the new employees entering into employment with the Company, in accordance with NASDAQ Listing Rule 5635(c)(4)....
Jul 21, 2017 04:01 pm ET
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
KING OF PRUSSIA, Pa., July 21, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company approved, effective as of July 17, 2017, the grant of inducement stock options to purchase 20,000 shares of the Company’s common stock to Sharon Davis, a new employee. These awards were granted pursuant to the Trevena, Inc. Inducement Plan as an inducement material to the new employees entering into employment with the Company, in accordance with NASDAQ Listing Rule 5635(c)(4). ...
Jun 20, 2017 04:01 pm ET
Trevena Attends National Institutes of Health Meeting to Discuss Development of Novel, Improved Pain Medications
KING OF PRUSSIA, Pa., June 20, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced its recent participation in the “Cutting Edge Science Meeting Series to End the Opioid Crisis: Development of Safe, Effective, Non-Addictive Pain Treatments” conference, held June 16, 2017 at the National Institutes of Health (NIH) Campus, Bethesda, MD. The conference gathered leading scientists and physicians from academia, industry, and government to discuss how new approaches to pain management might reduce risks to patients and communities who have suffered from the opioid crisis while i...
May 31, 2017 04:01 pm ET
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
KING OF PRUSSIA, Pa., May 31, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company approved, effective as of May 22, 2017 and May 30, 2017, the grant of inducement stock options to purchase an aggregate of 100,000 shares of the Company’s common stock to two new employees. These awards were granted pursuant to the Trevena, Inc. Inducement Plan as an inducement material to the new employees entering into employment with the Company, in accordance with NASDAQ Listing Rule 5635(c)(4). ...